Search research articles
Contact Us
Filters
Showing results (71-80 of 250) with videos related to
Page
of 25
Sort By:
Journal for Immunotherapy of Cancer
|
May 29, 2020
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, et al.
Scientific Reports
|
February 19, 2024
Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
Joo Young Kim, Jisup Kim, Yong-Il Kim, et al.
Investigational New Drugs
|
December 12, 2018
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis
Junho Kang, Changhoon Yoo, Hee-Sang Hwang, et al.
Liver Cancer
|
October 21, 2020
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
July 9, 2020
Prognostic implication of high grade biliary intraepithelial neoplasia in bile duct resection margins in patients with resected perihilar cholangiocarcinoma
Dakyum Shin, Sojung Lee, Jae Hoon Lee, et al.
Liver Cancer
|
April 21, 2025
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
Jiwon Yang, Won-Mook Choi, Hyung-Don Kim, et al.
European Radiology
|
August 20, 2020
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer
Ji Hun Kang, Seung Soo Lee, Jin Hee Kim, et al.
JCO Clinical Cancer Informatics
|
December 2, 2025
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning
Jamin Koo, Gyucheol Choi, Jaekyung Cheon, et al.
The Korean Journal of Internal Medicine
|
September 11, 2010
Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma
Changhoon Yoo, Shin Kim, Byeong Seok Sohn, et al.
Anticancer Research
|
August 28, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy
Jwa Hoon Kim, Changhoon Yoo, Hyehyun Jeong, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 250) with videos related to
Sort By:
Page
of 25
Journal for Immunotherapy of Cancer
|
May 29, 2020
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, et al.
Scientific Reports
|
February 19, 2024
Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
Joo Young Kim, Jisup Kim, Yong-Il Kim, et al.
Investigational New Drugs
|
December 12, 2018
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis
Junho Kang, Changhoon Yoo, Hee-Sang Hwang, et al.
Liver Cancer
|
October 21, 2020
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
July 9, 2020
Prognostic implication of high grade biliary intraepithelial neoplasia in bile duct resection margins in patients with resected perihilar cholangiocarcinoma
Dakyum Shin, Sojung Lee, Jae Hoon Lee, et al.
Liver Cancer
|
April 21, 2025
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
Jiwon Yang, Won-Mook Choi, Hyung-Don Kim, et al.
European Radiology
|
August 20, 2020
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer
Ji Hun Kang, Seung Soo Lee, Jin Hee Kim, et al.
JCO Clinical Cancer Informatics
|
December 2, 2025
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning
Jamin Koo, Gyucheol Choi, Jaekyung Cheon, et al.
The Korean Journal of Internal Medicine
|
September 11, 2010
Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma
Changhoon Yoo, Shin Kim, Byeong Seok Sohn, et al.
Anticancer Research
|
August 28, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy
Jwa Hoon Kim, Changhoon Yoo, Hyehyun Jeong, et al.
Page
of 25